Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-06

Clinical Trial Update: A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel [Phase 4]

View source ↗

Summary

Phase 4 trial update monitoring ambulatory blood pressure in hypogonadal men treated with nasal testosterone gel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • nasal testosterone gel (testosterone)

Snippet

Sponsor: Acerus Pharmaceuticals Corporation | Conditions: Hypogonadism | Phase 4 | Status: UNKNOWN